![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Baxter's Rixubis for Hemophilia B
FDA Approves Baxter's Rixubis for Hemophilia B
June 28, 2013
The FDA approved Baxter’s Rixubis, the first new drug for Hemophilia B in 15 years.
Pharma Times
Pharma Times
Upcoming Events
-
21Oct